| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.00056 | 1 |